Pharma major Lupin Limited (Lupin) won the Par Excellence Award at the 33rd National Convention on Quality Concept (NCQC), organised by the Quality Circle Forum of India (QCFI). The event was held at liT BHU – Varanasi from November 26-30, 2019. Lupin’s nomination summarised its transformation project to improve the yield and quality of Cefadroxi l products.
Speaking on the occasion, Rajendra B Chunodkar, President – Manufacturing Operations, Lupin said, “As a leading pharmaceutical company, we have persistently focused our efforts toward enabling manufacturing excellence at all our sites . This award endorses our approach and felicitates our efforts toward quality and continuous improvement.”
Twice in short succession, Lupin’s Ankleshwar facility received recognition for its “Cefadroxil Yield and Quality Improvement” project. In the previous instance, the facility won the gold award by the American Society for Quality at the Annual Conference on Quality Management in Ahmedabad.